Fuchs' Endothelial Corneal Dystrophy clinical trials at University of California Health
1 in progress, 0 open to eligible people
Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
Sorry, in progress, not accepting new patients
The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.
at UC Davis UCLA